Stay updated with breaking news from Vered Caplan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to unlock the full potential of cell and gene therapies (CGT) at the point of care, today announced that Vered Caplan, CEO of Orgenesis, will be participating in the Benchmark Company’s third Annual Healthcare House Call ...
Orgenesis announces collaboration agreement with SCTbio to expand POCare sites in the Czech Republic and enhance capabilities for the production of lentivirus vectors Germantown, Maryland, US and Prague, Czech Republic – May 18, 2023 – Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis”), a glob...
Orgenesis has secured $5 million from Metalmark Capital Partners to accelerate the growth of its point-of-care (POCare) services subsidiary.
Cell and gene therapies face a trio of challenges: increasing access, speeding up the process, and reducing the cost.
Operator: Greetings. Welcome to the Orgenesis 2022 Year End Business Update Conference Call. At this time, all participants are in a listen-only mode.